Warning. Research only: not approved by the FDA for any use in people. Information is for scientific awareness only. Not a recommendation to use, buy or compound.
No perspectives yet — be the first!
Be the first verified clinician to share how you read the research on LL-37.
100% anonymous · NPI-verifiedFDA status last checked Nov 11, 2026
A synthetic form of a human antimicrobial peptide (37 amino acids), belonging to the cathelicidin family, with antimicrobial, anti-inflammatory, immunostimulating and potential antineoplastic activities.
LL-37
Not approved for use in people. Mostly lab or animal research.
We have not yet attached proof for an evidence level.
There is no FDA-approved product with this peptide.
How it works. Proven facts and ideas still being studied are kept apart.
Not yet reviewed.
We have not yet attached proof for an evidence level.
Not FDA-approved. Nominations withdrawn from FDA's 503A category 2 (significant safety risk) list in 2026. Not on the 503A bulks list.
Last verified: Nov 11, 2026
Scientific views only. No use in patients or dosing is discussed.
Share your scientific view of the published evidence on LL-37.
Your view of the published research guides colleagues
Your name is never shown, only your specialty and region
About the published research. No use in patients or dosing
